Resveratrol may be beneficial in treatment of diabetic foot syndrome

Abstract Diabetic foot syndrome (DFS) is a late-stage complication of type 2 diabetes which originates from interplay among impaired tissue regeneration, vasculopathy, neuropathy and inflammation all on the background of insulin resistance. Despite astonishing mortality rate pharmacological approach...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medical hypotheses 2011-09, Vol.77 (3), p.364-367
Hauptverfasser: Bashmakov, Yuriy K, Assaad-Khalil, Samir, Petyaev, Ivan M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 367
container_issue 3
container_start_page 364
container_title Medical hypotheses
container_volume 77
creator Bashmakov, Yuriy K
Assaad-Khalil, Samir
Petyaev, Ivan M
description Abstract Diabetic foot syndrome (DFS) is a late-stage complication of type 2 diabetes which originates from interplay among impaired tissue regeneration, vasculopathy, neuropathy and inflammation all on the background of insulin resistance. Despite astonishing mortality rate pharmacological approach in management of diabetic ulceration is almost non-existent. Foot pressure relief, wound debridement and infection control remain widely accepted options in the treatment of DFS. We hypothesize that resveratrol treatment and subsequent activation of SIRT1 pathway might be highly beneficial for patients with DFS. This prediction is based on multiple lines of evidence implicating resveratrol and sirtuins in restoration of insulin sensitivity, microcirculation, tissue regeneration, function of peripheral nerves and production of cytokines. Stabilized “nutraceutical” formulations of resveratrol with high absorption rate are essential to examine its potential medical benefits since dietary polyphenols are known to be rapidly metabolized by gut microflora and oxidized during absorption. Clinical trials with nutraceutical formulations and placebo are required to understand if resveratrol indeed holds the promise for treatment of DFS.
doi_str_mv 10.1016/j.mehy.2011.05.016
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_885559089</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0306987711002271</els_id><sourcerecordid>885559089</sourcerecordid><originalsourceid>FETCH-LOGICAL-c410t-3dc1ee98dd93e5a8e4487f909a579591a08a80ae347cb5ba96f59847433f0be13</originalsourceid><addsrcrecordid>eNp9kU9r3DAQxUVoabZJv0AOwbee7M5Y1kqCUCj50xYChSQ9C1keU21tK5G0AX_72mzSQw-FgYHhvQfze4ydIVQIuP20q0b6NVc1IFYgquV0xDYoeF3WUso3bAMctqVWUh6z9yntAEA3XL1jxzVulVYaN-zqjtIzRZtjGIrRzkVLy0zUe-ftUPipyJFsHmnKReiLztuWsndFH0Iu0jx1MYx0yt72dkj04WWfsJ831w-X38rbH1-_X365LV2DkEveOSTSqus0J2EVNY2SvQZthdRCowVlFVjijXStaK3e9kKrRjac99AS8hP28ZD7GMPTnlI2o0-OhsFOFPbJKCWE0KD0oqwPShdDSpF68xj9aONsEMwKz-zMCs-s8AwIs5wW0_lL_L4dqftreaW1CC4OAlqefPYUTXKeJkedj-Sy6YL_f_7nf-xu8JN3dvhNM6Vd2MdpwWfQpNqAuV_rW9tDBKhrifwPrCmU9g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>885559089</pqid></control><display><type>article</type><title>Resveratrol may be beneficial in treatment of diabetic foot syndrome</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Bashmakov, Yuriy K ; Assaad-Khalil, Samir ; Petyaev, Ivan M</creator><creatorcontrib>Bashmakov, Yuriy K ; Assaad-Khalil, Samir ; Petyaev, Ivan M</creatorcontrib><description>Abstract Diabetic foot syndrome (DFS) is a late-stage complication of type 2 diabetes which originates from interplay among impaired tissue regeneration, vasculopathy, neuropathy and inflammation all on the background of insulin resistance. Despite astonishing mortality rate pharmacological approach in management of diabetic ulceration is almost non-existent. Foot pressure relief, wound debridement and infection control remain widely accepted options in the treatment of DFS. We hypothesize that resveratrol treatment and subsequent activation of SIRT1 pathway might be highly beneficial for patients with DFS. This prediction is based on multiple lines of evidence implicating resveratrol and sirtuins in restoration of insulin sensitivity, microcirculation, tissue regeneration, function of peripheral nerves and production of cytokines. Stabilized “nutraceutical” formulations of resveratrol with high absorption rate are essential to examine its potential medical benefits since dietary polyphenols are known to be rapidly metabolized by gut microflora and oxidized during absorption. Clinical trials with nutraceutical formulations and placebo are required to understand if resveratrol indeed holds the promise for treatment of DFS.</description><identifier>ISSN: 0306-9877</identifier><identifier>EISSN: 1532-2777</identifier><identifier>DOI: 10.1016/j.mehy.2011.05.016</identifier><identifier>PMID: 21689891</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Diabetic Foot - drug therapy ; Diabetic Foot - pathology ; Dietary Supplements ; Humans ; Insulin Resistance - physiology ; Internal Medicine ; Signal Transduction - drug effects ; Sirtuin 1 - metabolism ; Sirtuins - metabolism ; Stilbenes - pharmacology ; Stilbenes - therapeutic use ; Wound Healing - drug effects</subject><ispartof>Medical hypotheses, 2011-09, Vol.77 (3), p.364-367</ispartof><rights>Elsevier Ltd</rights><rights>2011 Elsevier Ltd</rights><rights>Copyright © 2011 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c410t-3dc1ee98dd93e5a8e4487f909a579591a08a80ae347cb5ba96f59847433f0be13</citedby><cites>FETCH-LOGICAL-c410t-3dc1ee98dd93e5a8e4487f909a579591a08a80ae347cb5ba96f59847433f0be13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0306987711002271$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21689891$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bashmakov, Yuriy K</creatorcontrib><creatorcontrib>Assaad-Khalil, Samir</creatorcontrib><creatorcontrib>Petyaev, Ivan M</creatorcontrib><title>Resveratrol may be beneficial in treatment of diabetic foot syndrome</title><title>Medical hypotheses</title><addtitle>Med Hypotheses</addtitle><description>Abstract Diabetic foot syndrome (DFS) is a late-stage complication of type 2 diabetes which originates from interplay among impaired tissue regeneration, vasculopathy, neuropathy and inflammation all on the background of insulin resistance. Despite astonishing mortality rate pharmacological approach in management of diabetic ulceration is almost non-existent. Foot pressure relief, wound debridement and infection control remain widely accepted options in the treatment of DFS. We hypothesize that resveratrol treatment and subsequent activation of SIRT1 pathway might be highly beneficial for patients with DFS. This prediction is based on multiple lines of evidence implicating resveratrol and sirtuins in restoration of insulin sensitivity, microcirculation, tissue regeneration, function of peripheral nerves and production of cytokines. Stabilized “nutraceutical” formulations of resveratrol with high absorption rate are essential to examine its potential medical benefits since dietary polyphenols are known to be rapidly metabolized by gut microflora and oxidized during absorption. Clinical trials with nutraceutical formulations and placebo are required to understand if resveratrol indeed holds the promise for treatment of DFS.</description><subject>Diabetic Foot - drug therapy</subject><subject>Diabetic Foot - pathology</subject><subject>Dietary Supplements</subject><subject>Humans</subject><subject>Insulin Resistance - physiology</subject><subject>Internal Medicine</subject><subject>Signal Transduction - drug effects</subject><subject>Sirtuin 1 - metabolism</subject><subject>Sirtuins - metabolism</subject><subject>Stilbenes - pharmacology</subject><subject>Stilbenes - therapeutic use</subject><subject>Wound Healing - drug effects</subject><issn>0306-9877</issn><issn>1532-2777</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9r3DAQxUVoabZJv0AOwbee7M5Y1kqCUCj50xYChSQ9C1keU21tK5G0AX_72mzSQw-FgYHhvQfze4ydIVQIuP20q0b6NVc1IFYgquV0xDYoeF3WUso3bAMctqVWUh6z9yntAEA3XL1jxzVulVYaN-zqjtIzRZtjGIrRzkVLy0zUe-ftUPipyJFsHmnKReiLztuWsndFH0Iu0jx1MYx0yt72dkj04WWfsJ831w-X38rbH1-_X365LV2DkEveOSTSqus0J2EVNY2SvQZthdRCowVlFVjijXStaK3e9kKrRjac99AS8hP28ZD7GMPTnlI2o0-OhsFOFPbJKCWE0KD0oqwPShdDSpF68xj9aONsEMwKz-zMCs-s8AwIs5wW0_lL_L4dqftreaW1CC4OAlqefPYUTXKeJkedj-Sy6YL_f_7nf-xu8JN3dvhNM6Vd2MdpwWfQpNqAuV_rW9tDBKhrifwPrCmU9g</recordid><startdate>20110901</startdate><enddate>20110901</enddate><creator>Bashmakov, Yuriy K</creator><creator>Assaad-Khalil, Samir</creator><creator>Petyaev, Ivan M</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20110901</creationdate><title>Resveratrol may be beneficial in treatment of diabetic foot syndrome</title><author>Bashmakov, Yuriy K ; Assaad-Khalil, Samir ; Petyaev, Ivan M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c410t-3dc1ee98dd93e5a8e4487f909a579591a08a80ae347cb5ba96f59847433f0be13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Diabetic Foot - drug therapy</topic><topic>Diabetic Foot - pathology</topic><topic>Dietary Supplements</topic><topic>Humans</topic><topic>Insulin Resistance - physiology</topic><topic>Internal Medicine</topic><topic>Signal Transduction - drug effects</topic><topic>Sirtuin 1 - metabolism</topic><topic>Sirtuins - metabolism</topic><topic>Stilbenes - pharmacology</topic><topic>Stilbenes - therapeutic use</topic><topic>Wound Healing - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bashmakov, Yuriy K</creatorcontrib><creatorcontrib>Assaad-Khalil, Samir</creatorcontrib><creatorcontrib>Petyaev, Ivan M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Medical hypotheses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bashmakov, Yuriy K</au><au>Assaad-Khalil, Samir</au><au>Petyaev, Ivan M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Resveratrol may be beneficial in treatment of diabetic foot syndrome</atitle><jtitle>Medical hypotheses</jtitle><addtitle>Med Hypotheses</addtitle><date>2011-09-01</date><risdate>2011</risdate><volume>77</volume><issue>3</issue><spage>364</spage><epage>367</epage><pages>364-367</pages><issn>0306-9877</issn><eissn>1532-2777</eissn><abstract>Abstract Diabetic foot syndrome (DFS) is a late-stage complication of type 2 diabetes which originates from interplay among impaired tissue regeneration, vasculopathy, neuropathy and inflammation all on the background of insulin resistance. Despite astonishing mortality rate pharmacological approach in management of diabetic ulceration is almost non-existent. Foot pressure relief, wound debridement and infection control remain widely accepted options in the treatment of DFS. We hypothesize that resveratrol treatment and subsequent activation of SIRT1 pathway might be highly beneficial for patients with DFS. This prediction is based on multiple lines of evidence implicating resveratrol and sirtuins in restoration of insulin sensitivity, microcirculation, tissue regeneration, function of peripheral nerves and production of cytokines. Stabilized “nutraceutical” formulations of resveratrol with high absorption rate are essential to examine its potential medical benefits since dietary polyphenols are known to be rapidly metabolized by gut microflora and oxidized during absorption. Clinical trials with nutraceutical formulations and placebo are required to understand if resveratrol indeed holds the promise for treatment of DFS.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>21689891</pmid><doi>10.1016/j.mehy.2011.05.016</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0306-9877
ispartof Medical hypotheses, 2011-09, Vol.77 (3), p.364-367
issn 0306-9877
1532-2777
language eng
recordid cdi_proquest_miscellaneous_885559089
source MEDLINE; Elsevier ScienceDirect Journals
subjects Diabetic Foot - drug therapy
Diabetic Foot - pathology
Dietary Supplements
Humans
Insulin Resistance - physiology
Internal Medicine
Signal Transduction - drug effects
Sirtuin 1 - metabolism
Sirtuins - metabolism
Stilbenes - pharmacology
Stilbenes - therapeutic use
Wound Healing - drug effects
title Resveratrol may be beneficial in treatment of diabetic foot syndrome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T21%3A53%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Resveratrol%20may%20be%20beneficial%20in%20treatment%20of%20diabetic%20foot%20syndrome&rft.jtitle=Medical%20hypotheses&rft.au=Bashmakov,%20Yuriy%20K&rft.date=2011-09-01&rft.volume=77&rft.issue=3&rft.spage=364&rft.epage=367&rft.pages=364-367&rft.issn=0306-9877&rft.eissn=1532-2777&rft_id=info:doi/10.1016/j.mehy.2011.05.016&rft_dat=%3Cproquest_cross%3E885559089%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=885559089&rft_id=info:pmid/21689891&rft_els_id=1_s2_0_S0306987711002271&rfr_iscdi=true